Karyopharm Therapeutics (KPTI) Return on Equity [ROE] (2013 - 2021)
Karyopharm Therapeutics' Return on Equity [ROE] came in at -3681.57% for Q1 2021, down 3508.95 percentage points from -172.62% a year earlier and down 3389.31 percentage points from the prior quarter.
Powered by 
Analysis
Karyopharm Therapeutics (KPTI) Return on Equity [ROE] (2013 - 2021) Analysis & Trends
For FY2020, Karyopharm Therapeutics' Return on Equity [ROE] was -391.29%, down 219.93 percentage points from FY2019.
- Return on Equity [ROE] has declined in each of the last six years, with a five-year change of -332.96 percentage points (FY2015 to FY2020).
- Going back by year, Return on Equity [ROE] was -171.36% in FY2019 (-57.23 pp), -114.13% in FY2018 (-25.70 pp), -88.43% in FY2017 (-27.66 pp) and -60.77% in FY2016 (-2.44 pp).
- The Q1 2021 figure represents the lowest quarterly Return on Equity [ROE] in data going back to Q4 2013.
- Year-over-year, Return on Equity [ROE] increased in three of the last eight quarters, with an average year-over-year change of -484.97 percentage points.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q3 2020 (a gain of 105.18 percentage points), and the weakest in Q1 2021 (a drop of 3508.95 percentage points).
- Business Quant data shows KPTI's Return on Equity [ROE] at -292.26% (Q4 2020), -188.70% (Q3 2020) and -127.98% (Q2 2020) in the three quarters before Q1 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Karyopharm Therapeutics | 35.30 Mn | -191.12 Mn | 32.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2021 | -3,681.57% |
| Dec 31, 2020 | -292.26% |
| Sep 30, 2020 | -188.70% |
| Jun 30, 2020 | -127.98% |
| Mar 31, 2020 | -172.62% |
| Dec 31, 2019 | -364.07% |
| Sep 30, 2019 | -293.88% |
| Jun 30, 2019 | -211.89% |
| Mar 31, 2019 | -135.40% |
| Dec 31, 2018 | -100.72% |
| Sep 30, 2018 | -82.82% |
| Jun 30, 2018 | -91.78% |
| Mar 31, 2018 | -122.25% |
| Dec 31, 2017 | -95.32% |
| Sep 30, 2017 | -75.83% |
| Jun 30, 2017 | -73.11% |
| Mar 31, 2017 | -74.71% |
| Dec 31, 2016 | -66.49% |
| Sep 30, 2016 | -69.70% |
| Jun 30, 2016 | -70.56% |
API Access
Karyopharm Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=KPTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "KPTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=KPTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();